POSC18 The Real-World Clinical Effectiveness of GLP-1 Receptor Agonist Liraglutide Among Patients with Type 2 Diabetes in China: Based on Existing Healthcare Data

Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.164
https://www.valueinhealthjournal.com/article/S1098-3015(21)01959-8/fulltext
Section Title :
Section Order : 10930
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01959-8&doi=10.1016/j.jval.2021.11.164
HEOR Topics :
Tags :
Regions :